Qualification
Medical Practitioner, MD (Diploma with Honor) Specialist in Internal Medicine Specialist in Endocrinology, Diabetes and Metabolic Diseases
Current post
Clinical research fellow, Diabetic Foot Clinic, King’s College Hospital, London, UK
PhD Student King’s College London
Prizes and grants
1999 Prize for Young Scientist of the Year 1999, Medical University of Varna, Bulgaria
2001-2004 Diabetes UK project grant: (BDA: RD 01 /002284)
Is there an underlying osteopenia in the diabetic neuropathic foot that predisposes to fracture and then the Charcot foot or does osteopenia only develop at the onset of the Charcot foot in the hyperaemic phase predisposing to multiple fractures and disorganisation?
Grant holders: ME Edmonds, AVM Foster, NL Petrova
2005-2008 Diabetes UK (BDA 05/0003025)
Does imbalance between RANKL and OPG lead to increased osteoclastic activity in acute Charcot osteoarthropathy and can the RANKL/OPG ratio act as a novel marker to monitor disease activity in the Charcot foot?
Grant holders: ME Edmonds, NL Petrova, C. Moniz, M, Bates, AN Donaldson
2006 EFSD AstraZeneca Clinical Travel Fellowship
2008 EFSD Albert Renold Fellowships for Young Scientists
2009-2012 Diabetes UK (BDA: 08/0003729)
A novel therapy using recombinant human PTH 1-84 to stimulate bone repair and enhance fracture healing in the acute Charcot foot: a double blind placebo controlled study
Grant holders: ME Edmonds, NL Petrova, C. Moniz, D. Elias, M, Bates, AN Donaldson, J Lord, S Pokrel
Postgraduate courses
Summer course in Clinical Epidemiology, Varna, Bulgaria- 1997
EASD Postgraduate course in Diabetology, Varna, Bulgaria-1998
Advanced course in diagnosis and treatment of osteoporosis, Medical University, Sofia, Bulgaria- 1999
EASD Robert Turner Clinical Research Course, Oxford, UK – 2004
Training course on “ Techniques of generating human osteoclasts in vitro”- Botnar Research Centre, University of Oxford- March 2006
Practical course on flow cytometry, Imperial College June 2008
List of publications
Petrova NL, Edmonds M. Charcot osteoarthropathy in type 1 and type 2 diabetes: are there differences? In “The Charcot foot and ankle: principles of management” edited by R Frykberg; Data Trace Publishing Company, in press.
Petrova NL, Edmonds ME. Charcot neuro-osteoarthropathy – current standards. Diabetes Metab Res Rev. 2008;24 Suppl 1:S58-61
Mabilleau G, Petrova NL, Edmonds ME, Sabokbar A. Increased osteoclastic activity in acute Charcot osteoarthropathy – The role of RANKL Diabetologia 2008;51(6):1035-40.
NL Petrova, C Moniz, DA Elias, M Buxton-Thomas, M Bates, ME Edmonds. Is there a systemic inflammatory response in the acute Charcot foot? Diabetes Care. 2007; 30(4):997-8.
Petrova N, Edmonds M. Emerging drugs for diabetic foot ulcers. Expert Opin Emerg Drugs. 2006;11(4):709-24.
Petrova NL, Foster AVM, Edmonds ME. Calcaneal Bone Mineral Density In Patients With Charcot Neuropathic Osteoarthropathy: Differences Between Type 1 And Type 2 Diabetes. Diabet Med 2005; 22:756-761.
Petrova NL, Edmonds ME. Charcot osteoarthropathy: one disease, two presentations. Biomedical Reviews 2005; 16: 43-48.
